TWD 90.5
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2.32 Billion TWD | 6.19% |
2022 | 2.18 Billion TWD | 8.23% |
2021 | 2.01 Billion TWD | -7.05% |
2020 | 2.17 Billion TWD | 6.43% |
2019 | 2.04 Billion TWD | 11.97% |
2018 | 1.82 Billion TWD | 5.04% |
2017 | 1.73 Billion TWD | 2.68% |
2016 | 1.68 Billion TWD | 4.2% |
2015 | 1.62 Billion TWD | 7.63% |
2014 | 1.5 Billion TWD | 4.35% |
2013 | 1.44 Billion TWD | 0.36% |
2012 | 1.43 Billion TWD | 7.08% |
2011 | 1.34 Billion TWD | 7.64% |
2010 | 1.24 Billion TWD | 10.04% |
2009 | 1.13 Billion TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 562.79 Million TWD | -0.21% |
2024 Q1 | 563.98 Million TWD | 8.5% |
2023 FY | 2.32 Billion TWD | 6.19% |
2023 Q4 | 519.78 Million TWD | -10.49% |
2023 Q3 | 580.71 Million TWD | -2.14% |
2023 Q2 | 593.39 Million TWD | -5.26% |
2023 Q1 | 626.32 Million TWD | 1.42% |
2022 Q2 | 488.68 Million TWD | -1.37% |
2022 Q4 | 617.57 Million TWD | 5.9% |
2022 FY | 2.18 Billion TWD | 8.23% |
2022 Q1 | 495.49 Million TWD | 2.02% |
2022 Q3 | 583.17 Million TWD | 19.34% |
2021 Q1 | 577.96 Million TWD | 9.22% |
2021 Q3 | 465.78 Million TWD | -4.81% |
2021 Q4 | 485.68 Million TWD | 4.27% |
2021 FY | 2.01 Billion TWD | -7.05% |
2021 Q2 | 489.31 Million TWD | -15.34% |
2020 Q1 | 493.95 Million TWD | 4.3% |
2020 Q4 | 529.17 Million TWD | -6.34% |
2020 Q3 | 565.02 Million TWD | -3.19% |
2020 FY | 2.17 Billion TWD | 6.43% |
2020 Q2 | 583.66 Million TWD | 18.16% |
2019 Q2 | 556.96 Million TWD | 15.38% |
2019 Q4 | 473.59 Million TWD | -10.2% |
2019 FY | 2.04 Billion TWD | 11.97% |
2019 Q1 | 482.71 Million TWD | -5.03% |
2019 Q3 | 527.36 Million TWD | -5.31% |
2018 FY | 1.82 Billion TWD | 5.04% |
2018 Q4 | 508.27 Million TWD | 6.1% |
2018 Q3 | 479.03 Million TWD | 12.11% |
2018 Q2 | 427.29 Million TWD | 4.77% |
2018 Q1 | 407.83 Million TWD | 3.07% |
2017 Q4 | 395.71 Million TWD | -15.21% |
2017 FY | 1.73 Billion TWD | 2.68% |
2017 Q2 | 447.68 Million TWD | 5.37% |
2017 Q1 | 424.87 Million TWD | 16.27% |
2017 Q3 | 466.7 Million TWD | 4.25% |
2016 Q2 | 452.42 Million TWD | 0.09% |
2016 Q3 | 419.8 Million TWD | -7.21% |
2016 FY | 1.68 Billion TWD | 4.2% |
2016 Q4 | 365.42 Million TWD | -12.95% |
2016 Q1 | 452.01 Million TWD | -2.77% |
2015 Q3 | 439.5 Million TWD | 24.26% |
2015 FY | 1.62 Billion TWD | 7.63% |
2015 Q1 | 363.48 Million TWD | -8.07% |
2015 Q4 | 464.87 Million TWD | 5.77% |
2015 Q2 | 353.7 Million TWD | -2.69% |
2014 Q1 | 371.81 Million TWD | 5.64% |
2014 Q3 | 376.47 Million TWD | 3.72% |
2014 FY | 1.5 Billion TWD | 4.35% |
2014 Q4 | 395.39 Million TWD | 5.03% |
2014 Q2 | 362.97 Million TWD | -2.38% |
2013 Q1 | 357.54 Million TWD | -7.24% |
2013 Q3 | 351.9 Million TWD | -8.0% |
2013 Q4 | 351.95 Million TWD | 0.01% |
2013 FY | 1.44 Billion TWD | 0.36% |
2013 Q2 | 382.5 Million TWD | 6.98% |
2012 FY | 1.43 Billion TWD | 7.08% |
2012 Q4 | 385.45 Million TWD | 4.46% |
2012 Q3 | 369.01 Million TWD | 8.02% |
2012 Q2 | 341.62 Million TWD | -0.29% |
2012 Q1 | 342.6 Million TWD | 13.0% |
2011 Q1 | 325.89 Million TWD | 2.38% |
2011 FY | 1.34 Billion TWD | 7.64% |
2011 Q4 | 303.18 Million TWD | -11.41% |
2011 Q3 | 342.24 Million TWD | -8.07% |
2011 Q2 | 372.29 Million TWD | 14.24% |
2010 Q1 | 299.79 Million TWD | 0.0% |
2010 FY | 1.24 Billion TWD | 10.04% |
2010 Q2 | 319.46 Million TWD | 6.56% |
2010 Q4 | 318.31 Million TWD | 2.44% |
2010 Q3 | 310.73 Million TWD | -2.73% |
2009 FY | 1.13 Billion TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
St.Shine Optical Co.,Ltd. | 4.39 Billion TWD | 47.195% |
Bioteque Corporation | 1.94 Billion TWD | -19.309% |
Chi Sheng Pharma & Biotech Co., Ltd | 1.06 Billion TWD | -118.709% |
Sunder Biomedical Tech. Co., Ltd. | 770.19 Million TWD | -201.251% |
BenQ Medical Technology Corporation | 4.54 Billion TWD | 48.928% |
Unicon Optical Co., Ltd. | 845.67 Million TWD | -174.362% |
Formosa Optical Technology Co.,Ltd. | 3.86 Billion TWD | 39.951% |
Medeon Biodesign, Inc. | 196.26 Million TWD | -1082.194% |
Concord Medical Co., Ltd. | 833.2 Million TWD | -178.469% |
Crystalvue Medical Corporation | 823.96 Million TWD | -181.591% |
Perfect Medical Industry Co., Ltd. | 734.13 Million TWD | -216.048% |
ICARES Medicus, Inc. | 605.45 Million TWD | -283.219% |
Lagis Enterprise Co., Ltd. | 459.93 Million TWD | -404.468% |
Amed Co., Ltd. | 763.82 Million TWD | -203.763% |